Denali Therapeutics (DNLI)

Denali Therapeutics (DNLI) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• DNLI last traded at $18.82, -0.63% on the day.
• Denali Therapeutics: market cap $3.03B, P/E -6.6, next earnings 2026-11-03.
• Over the past year DNLI returned 14.90%; year to date 13.99%.

Updated 2026-11-02 18:01 UTC